Expert consensus of the Chinese Association for the Study of Pain on ion channel drugs for neuropathic pain
- PMID: 33850929
- PMCID: PMC8017507
- DOI: 10.12998/wjcc.v9.i9.2100
Expert consensus of the Chinese Association for the Study of Pain on ion channel drugs for neuropathic pain
Abstract
Neuropathic pain (NPP) is a kind of pain caused by disease or damage impacting the somatosensory system. Ion channel drugs are the main treatment for NPP; however, their irregular usage leads to unsatisfactory pain relief. To regulate the treatment of NPP with ion channel drugs in clinical practice, the Chinese Association for the Study of Pain organized first-line pain management experts from China to write an expert consensus as the reference for the use of ion channels drugs . Here, we reviewed the mechanism and characteristics of sodium and calcium channel drugs, and developed recommendations for the therapeutic principles and clinical practice for carbamazepine, oxcarbazepine, lidocaine, bulleyaconitine A, pregabalin, and gabapentin. We hope this guideline provides guidance to clinicians and patients on the use of ion channel drugs for the management of NPP.
Keywords: Bulleyaconitine A; Carbamazepine; Expert consensus; Gabapentin; Guideline; Ion channel drug; Lidocaine; Neuropathic pain; Oxcarbazepine; Pregabalin.
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: The authors disclosure no conflict of interest.
Similar articles
-
Expert Consensus on Ion Channel Drugs for Chronic Pain Treatment in China.J Pain Res. 2024 Mar 8;17:953-963. doi: 10.2147/JPR.S445171. eCollection 2024. J Pain Res. 2024. PMID: 38476873 Free PMC article. Review.
-
Elucidation of pathophysiology and treatment of neuropathic pain.Cent Nerv Syst Agents Med Chem. 2012 Dec;12(4):304-14. doi: 10.2174/187152412803760645. Cent Nerv Syst Agents Med Chem. 2012. PMID: 23033930 Review.
-
Oxcarbazepine, topiramate, zonisamide, and levetiracetam: potential use in neuropathic pain.Am J Geriatr Pharmacother. 2003 Sep;1(1):18-37. doi: 10.1016/s1543-5946(03)80013-2. Am J Geriatr Pharmacother. 2003. PMID: 15555463 Review.
-
Guideline "diagnosis and non interventional therapy of neuropathic pain" of the German Society of Neurology (deutsche Gesellschaft für Neurologie).Neurol Res Pract. 2020 Jun 10;2:16. doi: 10.1186/s42466-020-00063-3. eCollection 2020. Neurol Res Pract. 2020. PMID: 33324922 Free PMC article.
-
Old Friends With New Faces: Are Sodium Channel Blockers the Future of Adjunct Pain Medication Management?J Pain. 2018 Jan;19(1):1-9. doi: 10.1016/j.jpain.2017.08.001. Epub 2017 Aug 24. J Pain. 2018. PMID: 28842369
Cited by
-
Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of Mirogabalin in Healthy Chinese Participants: A Randomized, Double-Blind, Placebo-Controlled Study.Adv Ther. 2023 Apr;40(4):1628-1643. doi: 10.1007/s12325-022-02424-7. Epub 2023 Feb 15. Adv Ther. 2023. PMID: 36790683 Free PMC article. Clinical Trial.
-
Expert Consensus on Ion Channel Drugs for Chronic Pain Treatment in China.J Pain Res. 2024 Mar 8;17:953-963. doi: 10.2147/JPR.S445171. eCollection 2024. J Pain Res. 2024. PMID: 38476873 Free PMC article. Review.
-
The Role of TNF-α in Neuropathic Pain: An Immunotherapeutic Perspective.Life (Basel). 2025 May 14;15(5):785. doi: 10.3390/life15050785. Life (Basel). 2025. PMID: 40430212 Free PMC article. Review.
-
Editorial for the special issue of the Chinese Association for the Study of Pain.World J Clin Cases. 2021 Mar 26;9(9):2022-2026. doi: 10.12998/wjcc.v9.i9.2022. World J Clin Cases. 2021. PMID: 33850921 Free PMC article.
-
Real-World Pharmacological Treatment Pattern of Neuropathic Pain in China: A Retrospective, Database, Multicenter Study (ReTARdant) Protocol.Pain Ther. 2025 Aug 11. doi: 10.1007/s40122-025-00767-x. Online ahead of print. Pain Ther. 2025. PMID: 40788612
References
-
- Jensen TS, Baron R, Haanpää M, Kalso E, Loeser JD, Rice ASC, Treede RD. A new definition of neuropathic pain. Pain. 2011;152:2204–2205. - PubMed
-
- van Hecke O, Austin SK, Khan RA, Smith BH, Torrance N. Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain. 2014;155:654–662. - PubMed
-
- Gierthmühlen J, Baron R. Neuropathic Pain. Semin Neurol. 2016;36:462–468. - PubMed
-
- Rivara M, Zuliani V. Novel sodium channel antagonists in the treatment of neuropathic pain. Expert Opin Investig Drugs. 2016;25:215–226. - PubMed
-
- Eisenberg E, River Y, Shifrin A, Krivoy N. Antiepileptic drugs in the treatment of neuropathic pain. Drugs. 2007;67:1265–1289. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources